profile picture
Oscar Abilez
Co-Founder & President
Bullseye Biotechnologies, Inc
I'm working on
4 months ago
Bullseye is making human pluripotent stem cell-derived "organoids-in-the-loop" for drug discovery and regenerative therapies. Our closed-loop system combines advanced human vascularized organoids (2025, Abilez et al., Science), automated microfluidics, and AI.
I'm looking for
5 months ago
We are looking to partner with pharma, academia, biotech, and R&D labs to create next-gen New Approach Methodologies (NAMS). We are open to co-developement, sponsored research, and pilot/trial engagement.
About
Oscar J. Abilez, MD, PhD is Co-Founder of Bullseye Biotechnologies and Senior Scientist at Stanford University. His research combines bioengineering, human pluripotent stem cells, and organoids to model the earliest stages of development and vascularization. At Bullseye, he is making "organoids-in-the-loop" for drug discovery. He trained in surgery at Stanford where he also received his PhD in Bioengineering. He received his MD from Cornell University and BS in Mechanical Engineering from UT-Austin. https://www.linkedin.com/in/oscarabilez
profile picture
Oscar Abilez
Co-Founder & President
Bullseye Biotechnologies, Inc
Work experience
Co-Founder & President
Senior Scientist
2021 - Present
Open to opportunities in
Artificial IntelligenceBiotechnologyCardiovascularCell AssemblyComputer ScienceDevelopmental Biology
Last updated Jun 2026
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.